Q3 FY2026 · ended Feb 28, 2026 · Revenue $11,205, -25.0% YoY · Filed Apr 16, 2026
Cannabis Bioscience International Holdings, Inc. (CBIH) files with the SEC under industry code 8731, Services-Commercial Physical & Biological Research. In Q3 of fiscal 2026, the quarter ended Feb 28, 2026, it reported revenue of $11,205 and a net loss of $103,933. As of Feb 28, 2026 it held $90 in cash and investments and $290,865 in total debt.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- CBIH (OTC)
- Fiscal year ends
- May 31
- Incorporated in
- CO
- Headquarters
- Yantis, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1411057
- Former names
- CHINA INFRASTRUCTURE CONSTRUCTION Corp (until Aug 24, 2022); FIDELITY AVIATION CORP (until Sep 15, 2009)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Feb 28, 2026 |
Q2 FY2026 Nov 30, 2025 |
Q1 FY2026 Aug 31, 2025 |
Q4 FY2025 May 31, 2025 |
Q3 FY2025 Feb 28, 2025 |
|---|---|---|---|---|---|
| Revenue | $11,205 | $53,266 | $24,200 | $34,956 | $14,931 |
| Operating income | -$93,259 | -$95,877 | -$74,784 | -$134,900 | -$129,234 |
| Net income | -$103,933 | -$116,966 | -$82,645 | -$211,744 | -$181,243 |
| Diluted EPS | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 |
| Operating cash flow | -$14,597 | -$5,493 | -$103,712 | -$144,312 | -$185,315 |
| Total assets | $1,544 | $22,131 | $18,942 | $31,880 | $14,886 |
| Total liabilities | $1.5M | $1.4M | $1.3M | $1.2M | $1.2M |
| Stockholders' equity | -$1.5M | -$1.4M | -$1.2M | -$1.2M | -$1.2M |
| Cash and investments | $90 | $132 | $223 | $12,952 | $548 |
| Total debt | $290,865 | $291,225 | $286,547 | $291,093 | $277,031 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Apr 16, 2026 | Feb 28, 2026 |
| 10-Q | Quarterly report | Feb 19, 2026 | Nov 30, 2025 |
| 10-Q | Quarterly report | Oct 22, 2025 | Aug 31, 2025 |
| 10-K | Annual report | Sep 22, 2025 | May 31, 2025 |
| 10-Q/A | Amended quarterly report | May 9, 2025 | Feb 28, 2025 |
| 10-Q | Quarterly report | Apr 22, 2025 | Feb 28, 2025 |
All 143 Cannabis Bioscience International Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.